Tobias Plaza
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.
Cerminara S, Cvijetic I, Huber S, Mueller S, Kostner L, Goessinger E, Narainsing J, Dutilh G, Heidemeyer K, Yawalkar N, Conrad C, Plaza T, Maul J, Cozzio A, Navarini A. ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis. J Eur Acad Dermatol Venereol 2024
Oct 24, 2024ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.
Oct 24, 2024J Eur Acad Dermatol Venereol 2024
Cerminara Sara Elisa, Cvijetic Ivana, Huber Stephanie, Mueller Simon M, Kostner Lisa, Goessinger Elisabeth V, Narainsing Jasmin, Dutilh Gilles, Heidemeyer Kristine, Yawalkar Nikhil, Conrad Curdin, Plaza Tobias, Maul Julia-Tatjana, Cozzio Antonio, Navarini Alexander A
Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification
Kempf W, Kazakov D, Cozzio A, Kamarashev J, Kerl K, Plaza T, Metze D. Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification. Am J Dermatopathol 2013; 35:159-66.
Apr 1, 2013Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification
Apr 1, 2013Am J Dermatopathol 2013; 35:159-66
Kempf Werner, Kazakov Dmitry V, Cozzio Antonio, Kamarashev Jivko, Kerl Katrin, Plaza Tobias, Metze Dieter